期刊文献+

肝去唾液酸糖蛋白受体显像:三维分段肝功能评估的前景 被引量:10

Liver asialoglycoprotein receptor scintigraphy:a new prospect of segmentational three-dimensional evaluation of liver function
下载PDF
导出
摘要 去唾液酸糖蛋白受体(ASGPR)是哺乳动物肝细胞表面的特异性受体,肝硬化和肝癌时ASGPR水平下降。利用99mTcGSA进行该受体的显像,能够得到HH15、LHL15、[R]0、R0等指标用于肝功能的评估;将这种功能性显像与单光子发射型计算机断层显像(SPECT)技术相结合,可以模拟肝脏切除的范围,并预测术后剩余肝脏的功能。此技术在国际上是一个新的课题,在国内尚无开展,用它来数字化的评估手术风险对患者手术方式的选择及预后具有重要影响。笔者结合正在进行的这方面部分研究,向读者作一介绍,以期在临床上发挥更好的作用。 Asialoglycoprotein receptor (ASGPR) is a specific receptor of mammalian hepatocytes. Reduction in ASGPR concentration has been proven to appear in liver cirrhosis and liver cancer. By liver ASGPR scintigraphy with ^99mTcGSA, some indexes such as HH15 ,LHL15, [ R] 0 ,R0 can be obtained, which is useful for the evaluation of liver function. When combining with the techniques of functional scintigraphy and single photon emission computed tomography (SPECT), it becomes possible to functionally simulate the extension of hepatic resection and predict to some extent postoperative outcomes related to liver function. It is still a new professional field internationally, and almost absent domestically. surgery and help determining the It could be an important tool for surgical procedures. We have here, field , written a review of ASGPR scintigraphy. quantificational evaluation of the risk of liver with some of our research experiences in this field , written a review of ASGPR scintigraphy.
作者 张涛 毛一雷
出处 《基础医学与临床》 CSCD 北大核心 2006年第5期538-541,共4页 Basic and Clinical Medicine
关键词 去唾液酸糖蛋白受体 99mTcGSA 肝切除术 剩余肝脏功能 asialoglycoprotein receptor ^99mTcGSA hepatic resection residual liver function
  • 相关文献

参考文献17

  • 1Sherman M.Hepatocellular carcinoma:epidemiology,risk factors,and screening[J].Semin Liver Dis,2005,25 (2):143-154.
  • 2Stockert R J,Morell AG.Hepatic binding protein:the galactose-specific receptor of mammalian hepatocytes[J].Hepatology,1983,3 (5):750-757.
  • 3Sawamura T,Nakada H,Hazama H,et al.Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma.Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma[J].Gastroenterology,1984,87(6):1217-1221.
  • 4Vera DR,Krohn KA,Stadalnik RC,et al.Tc-99m-galactosyl neoglycoalbumin:in vivo characterization of receptormediated binding to hepatocytes[J].Radiology,1984,151(1):191-196.
  • 5Sasaki N,Shiomi S,Iwata Y,et al.Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver[J].J Nucl Med,1999,40(10):1652-1656.
  • 6Vera DR,Stadalnik RC,Trudeau WL,et al.Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99mgalactosyl neoglycoalbumin[J].J Nucl Med,1991,32(6):1169-1176.
  • 7Kudo M,Todo A,Ikekubo K,et al.Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin[J].Hepatology,1993,17(5):814-819.
  • 8Vera DR,Stadalnik RC,Metz CE,et al.Diagnostic performance of a receptor-binding radiopharmacokinetic model[J].J Nucl Med,1996,37(1):160 -164.
  • 9Kokudo N,Vera DR,Tada K,et al.Predictors of successful hepatic resection:prognostic usefulness of hepatic asialoglycoprotein receptor analysis[J].World J Surg,2002,26(11):1342-1347.
  • 10Mullin EJ,Metcalfe MS,Maddern GJ.How much liver resection is too much?[J].Am J Surg,2005,190(1):87-97.

同被引文献114

引证文献10

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部